SECOND BRAIN - Trademark Details
Status: 604 - Abandoned - After Inter-Partes Decision
Image for trademark with serial number 88173138
Serial Number
88173138
Word Mark
SECOND BRAIN
Status
604 - Abandoned - After Inter-Partes Decision
Status Date
2020-03-09
Filing Date
2018-10-29
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2019-10-08
Attorney Name
Law Office Assigned Location Code
M90
Employee Name
DUBRAY, KATHERINE M
Statements
Goods and Services
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; preparations in the nature of a vaginal probiotic for the treatment and/or prevention of bacterial or fungal vaginal infection; nutraceuticals for the treatment and/or prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibers in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibers in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and/or nutritional and dietary supplements vaginal antifungal preparations; fungal and/or bacterial probiotics, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome; nutritional supplements, namely, probiotic compositions; diagnostic test kit comprised of medical diagnostic reagents and assays for the detection of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; diagnostic test kit comprised of medical diagnostic reagents and assays for the detection of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; diagnostic colon test kit comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Crohn's disease, ulcerative colitis, and irritable bowel syndrome; diagnostic colon cancer test kit comprised of medical diagnostic reagents and assays; diagnostic colorectal cancer screening test kit comprised of medical diagnostic reagents and assays; all of the aforementioned supplements and pharmaceutical products for human consumption containing probiotics; all of the aforementioned diagnostic kits testing levels of probiotics
Goods and Services
Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; Medical diagnostic testing services to apprise individuals and/or animals of the status of the gastrointestinal tract; Medical diagnostic testing services to apprise individuals and/or animals of the status of the large intestine; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the gastrointestinal tract; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the large intestine; providing educational information in the field of the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganism, probiotics, cancer and/or pathogens in the gastrointestinal tract; providing educational information in the field of the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganism, probiotics, cancer and/or pathogens in the large intestine; providing educational information in the field of the gastrointestinal tract and how to have and maintain and/or monitor a healthy gastrointestinal tract; providing educational information in the field of the gastrointestinal tract and how to have and maintain and/or monitor a healthy large intestine
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
8 - Abandoned
Class Status Date
2020-03-09
Primary Code
005
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
8 - Abandoned
Class Status Date
2020-03-09
Primary Code
044
Correspondences
Name
BRIAN E TURUNG
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-11-13NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-01-30AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2019-02-04ASSIGNED TO EXAMINER
2019-02-28NON-FINAL ACTION WRITTEN
2019-02-28NON-FINAL ACTION E-MAILED
2019-02-28NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-08-13TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-08-13CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-08-13TEAS/EMAIL CORRESPONDENCE ENTERED
2019-08-30APPROVED FOR PUB - PRINCIPAL REGISTER
2019-09-05ASSIGNED TO LIE
2019-09-18NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-10-08PUBLISHED FOR OPPOSITION
2019-10-08OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-11-05EXTENSION OF TIME TO OPPOSE RECEIVED
2019-12-06OPPOSITION INSTITUTED NO. 999999
2020-03-09OPPOSITION SUSTAINED NO. 999999
2020-03-09OPPOSITION TERMINATED NO. 999999
2020-03-09ABANDONMENT - AFTER INTER PARTES DECISION
2020-03-09ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION